Product Information
MICARDIS HCT 80-25 MG TABLET is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $4.4768 per EA under NDC 00597004237. Its NADAC has been published 444 times since Nov 28, 2013.
FDA first approved this application on Nov 17, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the telmisartan and hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25; 80 mg/1; mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597004237
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
1/21/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; TELMISARTANApproval Type
New Drug (NDA)
FDA Application
NDA021162FDA Approved
11/17/2000
TE Code
AB
On Market Since
12/1/2000
Pharmacological Classes
Price Statistics
The NADAC for MICARDIS HCT 80-25 MG TABLET has been published 444 times since Nov 28, 2013, and over the history we have for it it has risen 2.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4768 per EA |
|---|---|
| All-time high | $6.9029 (Jan 15, 2020) |
| All-time low | $4.3220 (Dec 18, 2013) |
| 52-week high | $4.4939 |
| 52-week low | $4.4768 |
| Median price | $5.2199 |
| Average price | $5.4514 |
| Largest weekly change | -34.5% (Apr 17, 2024) |
| Weeks tracked | 444 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 92% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MICARDIS HCT 80-25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MICARDIS HCT 80-25 MG TABLET, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $4.4768 per EA (NDC 00597004237), effective Aug 19, 2026.
How has the price of MICARDIS HCT 80-25 MG TABLET changed over time?
Over the history we have for it, the NADAC for MICARDIS HCT 80-25 MG TABLET has risen 2.0%. It has been tracked across 444 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MICARDIS HCT 80-25 MG TABLET?
Since Nov 28, 2013, the NADAC for MICARDIS HCT 80-25 MG TABLET has ranged from a low of $4.3220 (Dec 18, 2013) to a high of $6.9029 (Jan 15, 2020), with a median of $5.2199 per EA.
Are there cheaper alternatives to MICARDIS HCT 80-25 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TELMISARTAN-HYDROCHLOROTHIAZIDE 80-25 MG TAB, is $0.3547 per EA — about 92% below MICARDIS HCT 80-25 MG TABLET.
Who manufactures MICARDIS HCT 80-25 MG TABLET?
MICARDIS HCT 80-25 MG TABLET (NDC 00597004237) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.